These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38927691)

  • 41. Integrated single-cell and bulk RNA-Seq analysis enhances prognostic accuracy of PD-1/PD-L1 immunotherapy response in lung adenocarcinoma through necroptotic anoikis gene signatures.
    Sui P; Liu X; Zhong C; Sha Z
    Sci Rep; 2024 May; 14(1):10873. PubMed ID: 38740918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HArmonized single-cell RNA-seq Cell type Assisted Deconvolution (HASCAD).
    Chiu YJ; Ni CE; Huang YH
    BMC Med Genomics; 2023 Oct; 16(Suppl 2):272. PubMed ID: 37907883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and validation of a novel predictive signature based on hepatocyte-specific genes in hepatocellular carcinoma by integrated analysis of single-cell and bulk RNA sequencing.
    He Y; Qi W; Xie X; Jiang H
    BMC Med Genomics; 2024 Apr; 17(1):103. PubMed ID: 38654290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrating scRNA and bulk-RNA sequencing develops a cell senescence signature for analyzing tumor heterogeneity in clear cell renal cell carcinoma.
    Gong Q; Jiang Y; Xiong J; Liu F; Guan J
    Front Immunol; 2023; 14():1199002. PubMed ID: 37503331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single-cell RNA-seq reveals invasive trajectory and determines cancer stem cell-related prognostic genes in pancreatic cancer.
    Ren X; Zhou C; Lu Y; Ma F; Fan Y; Wang C
    Bioengineered; 2021 Dec; 12(1):5056-5068. PubMed ID: 34474642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq.
    Zhang P; Liu J; Pei S; Wu D; Xie J; Liu J; Li J
    Front Immunol; 2023; 14():1189520. PubMed ID: 37256127
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
    Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
    Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrating Bulk and Single-Cell RNA Sequencing Reveals Heterogeneity, Tumor Microenvironment, and Immunotherapeutic Efficacy Based on Sialylation-Related Genes in Bladder Cancer.
    Tan Z; Chen X; Zuo J; Fu S; Wang J; Wang H
    J Inflamm Res; 2023; 16():3399-3417. PubMed ID: 37600224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. iBRIDGE: A Data Integration Method to Identify Inflamed Tumors from Single-cell RNA-Seq Data and Differentiate Cell Type-Specific Markers of Immune-Cell Infiltration.
    Turan T; Kongpachith S; Halliwill K; McLaughlin RT; Binnewies M; Reddy D; Zhao X; Mathew R; Ye S; Jacob HJ; Samayoa J
    Cancer Immunol Res; 2023 Jun; 11(6):732-746. PubMed ID: 37023414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single-cell RNA-Seq and bulk RNA-Seq reveal reliable diagnostic and prognostic biomarkers for CRC.
    Zhang X; Yang L; Deng Y; Huang Z; Huang H; Wu Y; He B; Hu F
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9805-9821. PubMed ID: 37247080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single-Cell RNA Sequencing Reveals the Role of Epithelial Cell Marker Genes in Predicting the Prognosis of Colorectal Cancer Patients.
    Shen KY; Chen BY; Gao WC
    Dis Markers; 2022; 2022():8347125. PubMed ID: 35968507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decoding temporal heterogeneity in NSCLC through machine learning and prognostic model construction.
    Cheng J; Xiao M; Meng Q; Zhang M; Zhang D; Liu L; Jin Q; Fu Z; Li Y; Chen X; Xie H
    World J Surg Oncol; 2024 Jun; 22(1):156. PubMed ID: 38872167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery of a novel lipid metabolism-related gene signature to predict outcomes and the tumor immune microenvironment in gastric cancer by integrated analysis of single-cell and bulk RNA sequencing.
    Zhang J; Wang H; Tian Y; Li T; Zhang W; Ma L; Chen X; Wei Y
    Lipids Health Dis; 2023 Dec; 22(1):212. PubMed ID: 38042786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comprehensive analysis of bulk and single-cell transcriptomic data reveals a novel signature associated with endoplasmic reticulum stress, lipid metabolism, and liver metastasis in pancreatic cancer.
    Liu X; Ren B; Fang Y; Ren J; Wang X; Gu M; Zhou F; Xiao R; Luo X; You L; Zhao Y
    J Transl Med; 2024 Apr; 22(1):393. PubMed ID: 38685045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma.
    Bai J; Tang R; Zhou K; Chang J; Wang H; Zhang Q; Shi J; Sun C
    BMC Med Genomics; 2022 Oct; 15(1):222. PubMed ID: 36284275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils Novel Prognostic Biomarkers in Multiple Myeloma.
    Zhao J; Wang X; Zhu H; Wei S; Zhang H; Ma L; He P
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intra-tumor heterogeneity and prognostic risk signature for hepatocellular carcinoma based on single-cell analysis.
    Liu C; Pu M; Ma Y; Wang C; Kong L; Zhang S; Zhao X; Lian X
    Exp Biol Med (Maywood); 2022 Oct; 247(19):1741-1751. PubMed ID: 36330895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
    Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
    Front Immunol; 2021; 12():734646. PubMed ID: 34795663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single Cell RNA-Seq Identifies Immune-Related Prognostic Model and Key Signature-SPP1 in Pancreatic Ductal Adenocarcinoma.
    Chen K; Wang Q; Liu X; Wang F; Ma Y; Zhang S; Shao Z; Yang Y; Tian X
    Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.